Eph receptor tyrosine kinases in tumor and tumor microenvironment.
about
Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesisEphs and Ephrins in malignant gliomasRegulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesisThe receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signalingCooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis.Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient EndotheliumDiscovery and characterization of a novel cyclic peptide that effectively inhibits ephrin binding to the EphA4 receptor and displays anti-angiogenesis activityAn efficient rapid system for profiling the cellular activities of molecular libraries.Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro.High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer.Enabling individualized therapy through nanotechnologyStriking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progressionEph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice.Phosphorylation of ephrin-B1 via the interaction with claudin following cell-cell contact formation.Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesisTyrosine kinase inhibitors: Multi-targeted or single-targeted?Eph receptors and ephrins as targets for cancer therapy.EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).The simultaneous expression of both ephrin B3 receptor and E-cadherin in Barrett`s adenocarcinoma is associated with favorable clinical staging.Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.Eph receptors in breast cancer: roles in tumor promotion and tumor suppression.Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival.Eph receptors and ephrin signaling pathways: a role in bone homeostasis.MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cellsEPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathyDancing with the dead: Eph receptors and their kinase-null partners.EphrinA I-targeted nanoshells for photothermal ablation of prostate cancer cells.Specific and shared targets of ephrin A signaling in epidermal keratinocytesReduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor.Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer.Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor-mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis.Clinical implications of EphB4 receptor expression in pancreatic cancer.Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival.The intrinsically kinase-inactive EPHB6 receptor predisposes cancer cells to DR5-induced apoptosis by promoting mitochondrial fragmentation.Eph-2B, acting as an extracellular ligand, induces differentiation markers in epidermal keratinocytes.
P2860
Q21328694-A1E162B0-D517-41E2-A525-E411B62088CCQ27015780-FD98A124-FE41-4541-8E33-D5D19718B3A5Q28585388-8277477A-C4EE-49CB-9ECE-41785DEA6942Q28586276-D6A7E8FC-D49E-4BC1-B084-C29F579E70AAQ30480823-24533812-2873-4D2E-8E0C-39AA4FF3F5EBQ30498003-181517C4-8D50-4CFE-B881-C3CA9E4E2337Q30646148-D87F2EC7-0D19-46BC-B47B-3CA1287683E3Q31144324-BE5BD33C-418E-48DC-ADE1-434E0213E057Q33234459-1B40134B-A11F-4EC6-A9E8-1C18922EAF6CQ33687354-96DE3920-5920-4A05-8D57-9564CFEC77D2Q33702374-BED05A1E-DC58-4F7C-9E37-D84F8B40451EQ33917755-F1AC825C-231F-44B1-BC0F-210EDF9B7765Q33965278-A0E18382-F0E0-4D92-8EED-6F290E2DB234Q34026097-989E438C-45E2-409C-AAF6-F5C496861705Q34031959-5D02FE4D-675B-4526-BC55-F7376A8CBC0BQ34100286-5DB6E64F-FE53-4EA1-82F9-B9EC743EFC70Q34116905-27AD9A18-E5DD-486B-88EC-0D7DA4ECA94EQ34540120-A7799E70-65CF-4D45-8073-7C12C6F078A2Q34983846-7BEE1F5A-92B4-45F6-A082-A08008C7952EQ35370195-82758983-CFA9-4680-BB44-B43EF3328C57Q35692688-A5A969B0-640A-48F0-8FA5-29CBD9816C8DQ35773939-30121429-65ED-4171-9F97-60D88D47BBDCQ36316605-49A9E229-1C39-4361-A42A-E7CD93074F11Q36701792-006A333F-0794-4072-8C1E-3AA35A7C72BDQ37131357-A7381AB4-4009-4049-845D-550D1BD70883Q37160698-04417060-3B49-4990-8D39-D933F6B08B92Q37271460-66FA93B7-9BB6-4EB4-9150-27BFBB615247Q37298299-0D6BC814-B928-4942-85C0-6559ADFA19BFQ37350976-A601DEA6-2B52-47B5-9A43-E623A95E7EEDQ37735014-C077D460-61A1-40A8-958C-7F27164643A5Q37860149-65FED751-B6D6-464C-8269-87D89DDC867AQ38498023-93582288-41D9-4233-83F4-3C95A1F85DC3Q38503847-FA27E918-DC3B-43A5-AF5C-E4C84206C5AFQ38814701-D1EE4A64-F8D9-4F9B-9085-C70C66753813Q38838986-CCFD5FF1-2CE9-4A89-B360-5AF893E34B27Q39211247-6FAEF1F5-5CDF-4CDD-96CD-27CE75CEFA3AQ39256747-83F49E13-3198-4CE1-AD96-AAD05E5B55BAQ39393366-3395E3C4-E5B4-47F2-9290-7DDB881E171FQ42314590-8FE21EB8-0463-4832-8101-41194866489AQ42492492-445A1D87-9C1B-4E8C-AAC6-33CD03AD4583
P2860
Eph receptor tyrosine kinases in tumor and tumor microenvironment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Eph receptor tyrosine kinases in tumor and tumor microenvironment.
@ast
Eph receptor tyrosine kinases in tumor and tumor microenvironment.
@en
type
label
Eph receptor tyrosine kinases in tumor and tumor microenvironment.
@ast
Eph receptor tyrosine kinases in tumor and tumor microenvironment.
@en
prefLabel
Eph receptor tyrosine kinases in tumor and tumor microenvironment.
@ast
Eph receptor tyrosine kinases in tumor and tumor microenvironment.
@en
P2093
P356
P1476
Eph receptor tyrosine kinases in tumor and tumor microenvironment.
@en
P2093
Dana Brantley-Sieders
Monica Parker
Sonja Schmidt
P304
P356
10.2174/1381612043383160
P577
2004-01-01T00:00:00Z